Robert Eugene Kristal - 17 Feb 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role: Chief Financial Officer
Signature: /s/ Robert Kristal
Issuer symbol: BRTX
Transactions as of: 17 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 17 Feb 2023, 16:32:00 UTC
Previous filing: 04 Nov 2022
Next filing: 15 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BRTX	Common Stock						7,994	17 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRTX	Stock Option	Award	$0	+88,968		$0.000000	88,968	17 Feb 2023	Common Stock	88,968	$2.91	Direct	F2
holding	BRTX	Stock Option						10,490	17 Feb 2023	Common Stock	10,490	$5.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2	The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.